This article is more than 5 years old. Information may no longer be current.

VIDEO: Lesinurad should be combined with XOIs

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WASHINGTON — At the American College of Rheumatology Annual Meeting, Robert Terkeltaub, MD, in the division of rheumatology at the VA Medical Center in San Diego, California, reviewed his pooled safety study from the phase 3 program of lesinurad in gout in which there was an increase in safety signal.

As a take-home message for clinical practices, Terkeltaub said it is important to use lesinurad in combination with a xanthine oxidase inhibitor (XOI).